Literature DB >> 18240907

Role of OATP transporters in the disposition of drugs.

Mikko Niemi1.   

Abstract

During recent years, it has become increasingly recognized that drug transporters play important roles in drug absorption and disposition. Organic anion transporting polypeptides (OATPs) are membrane transporters critically involved in the cellular uptake of drugs in tissues important for pharmacokinetics, such as the intestine, liver and kidneys. Recent advances in the pharmacogenomics of OATP1B1 have revealed that OATP transporters can play important roles in explaining interindividual variability in drug pharmacokinetics, and thus contribute to interindividual as well as interethnic variability in drug response. This article will provide an up-to-date review of human OATPs and their substrates, and a current compilation of their DNA sequence variations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18240907     DOI: 10.2217/14622416.8.7.787

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  61 in total

1.  Organic anion transporting polypeptide 1a/1b-knockout mice provide insights into hepatic handling of bilirubin, bile acids, and drugs.

Authors:  Evita van de Steeg; Els Wagenaar; Cornelia M M van der Kruijssen; Johanna E C Burggraaff; Dirk R de Waart; Ronald P J Oude Elferink; Kathryn E Kenworthy; Alfred H Schinkel
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

2.  Downregulation of Organic Anion Transporting Polypeptide (OATP) 1B1 Transport Function by Lysosomotropic Drug Chloroquine: Implication in OATP-Mediated Drug-Drug Interactions.

Authors:  Khondoker Alam; Sonia Pahwa; Xueying Wang; Pengyue Zhang; Kai Ding; Alaa H Abuznait; Lang Li; Wei Yue
Journal:  Mol Pharm       Date:  2016-02-01       Impact factor: 4.939

3.  Dehydroepiandrosterone sulfate directly activates protein kinase C-beta to increase human neutrophil superoxide generation.

Authors:  David J Radford; Keqing Wang; Joanne C McNelis; Angela E Taylor; Georg Hechenberger; Johann Hofmann; Hema Chahal; Wiebke Arlt; Janet M Lord
Journal:  Mol Endocrinol       Date:  2010-02-19

4.  Interaction potential of etravirine with drug transporters assessed in vitro.

Authors:  Nadine Cécile Luise Zembruski; Walter Emil Haefeli; Johanna Weiss
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

Review 5.  Genetic variation in drug transporters in ethnic populations.

Authors:  C D Cropp; S W Yee; K M Giacomini
Journal:  Clin Pharmacol Ther       Date:  2008-06-04       Impact factor: 6.875

6.  Comparative bioinformatics, temporal and spatial expression analyses of Ixodes scapularis organic anion transporting polypeptides.

Authors:  Zeljko Radulović; Lindsay M Porter; Tae K Kim; Albert Mulenga
Journal:  Ticks Tick Borne Dis       Date:  2014-02-25       Impact factor: 3.744

Review 7.  Pharmacokinetic comparison of the potential over-the-counter statins simvastatin, lovastatin, fluvastatin and pravastatin.

Authors:  Pertti J Neuvonen; Janne T Backman; Mikko Niemi
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

8.  Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.

Authors:  Lisa R Treviño; Noriko Shimasaki; Wenjian Yang; John C Panetta; Cheng Cheng; Deqing Pei; Diana Chan; Alex Sparreboom; Kathleen M Giacomini; Ching-Hon Pui; William E Evans; Mary V Relling
Journal:  J Clin Oncol       Date:  2009-11-09       Impact factor: 44.544

9.  PharmGKB very important pharmacogene: SLCO1B1.

Authors:  Connie Oshiro; Lara Mangravite; Teri Klein; Russ Altman
Journal:  Pharmacogenet Genomics       Date:  2010-03       Impact factor: 2.089

10.  Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers.

Authors:  Yu Cheng; Guo Wang; Wei Zhang; Lan Fan; Yao Chen; Hong-Hao Zhou
Journal:  Eur J Clin Pharmacol       Date:  2012-07-28       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.